Does Medicare Cover Ozempic?
Medicare covers Ozempic for type 2 diabetes and not for weight loss. Coverage turns on the diagnosis your doctor submits. Here is what to expect on cost and approvals.
Yes, if you have type 2 diabetes. Medicare Part D covers Ozempic (semaglutide) for its FDA-approved uses: treating type 2 diabetes, and lowering cardiovascular risk in people who have both diabetes and heart disease. Part D does not cover Ozempic prescribed only for weight loss, because federal law excludes weight-loss drugs from Part D. Ozempic is also not in the Medicare GLP-1 Bridge program, which covers drugs labeled for weight loss.
Two questions get mixed together: whether Medicare covers the drug, and whether Medicare covers weight loss. For Ozempic, the answer depends on the diagnosis code on the prescription. Knowing that ahead of time helps you avoid a denied claim at the pharmacy.
| Drug | Active ingredient | FDA-approved for | Medicare coverage |
|---|---|---|---|
| Ozempic | Semaglutide | Type 2 diabetes | Part D, for diabetes |
| Wegovy | Semaglutide | Weight management | GLP-1 Bridge, $50 a month |
| Mounjaro | Tirzepatide | Type 2 diabetes | Part D, for diabetes |
| Zepbound KwikPen | Tirzepatide | Weight management, sleep apnea | GLP-1 Bridge, $50 a month |
Why the FDA-approved use matters
The FDA approved Ozempic to treat type 2 diabetes. It later added an approval for lowering the risk of heart attack, stroke and cardiovascular death in adults with type 2 diabetes and known heart disease. Weight loss is a common effect, and some doctors prescribe Ozempic off-label for it.
Medicare treats those two situations differently. Drugs used for weight loss have been excluded from Part D since the program began. A Part D plan cannot cover Ozempic, or any GLP-1 drug, when the prescription shows it is for weight loss and not an approved condition.
What Original Medicare and Part D pay for
Original Medicare (Parts A and B) does not cover drugs you inject yourself at home, such as Ozempic. Part D covers them, through a stand-alone drug plan or a Medicare Advantage plan with drug coverage. If you have type 2 diabetes and your plan lists Ozempic, expect the following.
Formulary placement
Ozempic is a brand-name drug and often sits on a higher tier, which means a higher copay or coinsurance than generic diabetes drugs.
Prior authorization
Many plans ask your doctor to confirm the type 2 diabetes diagnosis first. Some require step therapy, meaning you try other diabetes drugs before Ozempic.
Deductible and yearly cap
You may pay full price until you meet the plan's deductible (up to $615 in 2026). Your total out-of-pocket drug costs for the year are capped at $2,100 in 2026.
Plan-to-plan variation
Not every Part D plan covers Ozempic, and copays differ between plans. Compare formularies during open enrollment.
What it costs in 2026 and 2027
Part D no longer has a coverage gap, or "donut hole." It ended in 2025. There are now three stages: the deductible, then your plan's copay or coinsurance, then $0 for covered drugs once you reach the yearly cap.
- 2026: deductible up to $615, out-of-pocket cap $2,100.
- 2027: deductible up to $700, out-of-pocket cap $2,400.
Because Ozempic is expensive, people who take it often meet the deductible in the first month or two. If the early-year bills are hard to manage, ask your plan about the Medicare Prescription Payment Plan. It spreads your out-of-pocket drug costs across the year in monthly payments. It does not lower the total.
Semaglutide is also one of the drugs with a Medicare-negotiated price that takes effect January 1, 2027. What you pay will still depend on your plan, so check 2027 plan details during open enrollment, October 15 to December 7.
Ozempic and the Medicare GLP-1 Bridge program
The Medicare GLP-1 Bridge is a temporary CMS demonstration that began July 1, 2026 and runs through December 31, 2027. Eligible members of participating Part D and Medicare Advantage drug plans can get certain GLP-1 drugs for weight loss at a flat $50 copay per 30-day supply.
Ozempic is not included. The Bridge covers Wegovy (injection and tablets), the Zepbound KwikPen and Foundayo, which are approved for weight loss or weight management. Ozempic and Mounjaro are labeled as diabetes drugs, so they are left out.
If you want Medicare coverage for weight loss, ask your doctor about Wegovy under the Bridge program. If you take Ozempic for diabetes, the Bridge changes nothing for you. Your plan's regular Part D benefit applies.
How to check your specific plan
Search your plan's formulary for "semaglutide" or "Ozempic" in the member portal, or call the number on your plan card. Ask three questions:
- Is Ozempic on the formulary?
- Which tier is it on, and what is my copay?
- Does it need prior authorization or step therapy?
Your prescriber's office can send the prior authorization request for you.
If the cost is still too high, check whether you qualify for Extra Help, the federal program that lowers Part D premiums, deductibles and copays for people with limited income and resources.
Frequently Asked Questions
Does Medicare cover Ozempic for weight loss?
Generally no. Federal law excludes drugs used for weight loss from Medicare Part D. Ozempic is FDA-approved for type 2 diabetes, and for lowering cardiovascular risk in people with diabetes and heart disease. A Part D plan can cover it for those uses, not as an off-label weight-loss prescription.
Is Ozempic covered under the new Medicare GLP-1 Bridge program?
No. The Medicare GLP-1 Bridge, a temporary CMS demonstration that began July 1, 2026, covers Wegovy, the Zepbound KwikPen and Foundayo for weight loss at a $50 monthly copay. Ozempic is approved as a diabetes drug, so it is covered only through regular Part D.
What's the difference between Ozempic and Wegovy?
Both contain semaglutide and come from the same manufacturer. Ozempic is FDA-approved for type 2 diabetes. Wegovy is approved for chronic weight management. Medicare follows the approved use on the label, so it treats them differently.
Will my Part D plan cover Ozempic automatically if I have diabetes?
No. The plan has to list Ozempic on its formulary, and many plans require prior authorization or step therapy showing you tried other diabetes drugs first. Coverage and copays differ by plan, so check your formulary or call your plan.
What if my doctor prescribes Ozempic off-label for weight loss?
If the prescription and diagnosis code show a use other than type 2 diabetes, your Part D plan can deny the claim under the weight-loss drug exclusion. You would likely pay the full cash price.
This article is for general educational purposes and reflects Medicare rules as of October 2026. It is not medical or insurance advice. Coverage depends on your diagnosis, prescription and plan. Confirm the details with your doctor and your Medicare Part D or Medicare Advantage plan.